Table 6 Reported frequencies of IDH1 and IDH2 mutations in APL patients worldwide
Country | No. IDH1m/all cases (%) | No. of IDH1m in APL (%) | No. IDH2m/all cases (%) | No. of IDH2m in APL (%) |
|---|---|---|---|---|
ASIA | Â | Â | Â | Â |
Taiwan | Â | Â | Â | Â |
Chou W et al.[18] | 27/493 (5.5) | 0/37 (0) | ND | ND |
China | Â | Â | Â | Â |
Zhang Y et al.[28] | 23/365 (6.3) | 3/77 (3.9) | ND | ND |
Thailand | Â | Â | Â | Â |
This study | 20/230 (8.7) | 5/36(13.9) | 24/230 (10.4) | 6/36 (16.7) |
EUROPE | Â | Â | Â | Â |
Germany | Â | Â | Â | Â |
Schnittger S et al.[27] | 93/1414 (6.6) | 2/88 (2.3) | ND | ND |
The Netherlands | Â | Â | Â | Â |
Abbas S et al.[24] | 55/893 (6.2) | 0/21 (0) | 97/893 (10.9) | 0/21 (0) |
NORTH AMERICA | Â | Â | Â | Â |
United States | Â | Â | Â | Â |
Mardis E et al.[5] | 16/188 (8.5) | 0/16 (0) | ND | ND |
Andersson A et al.[29] | 5/227 (2.2) | 0/7 (0) | 3/227 (1.3) | 0/7 (0) |